Article Type

16 - 30 of 1054 Results       Clear All

What If Cells Kept Receipts of Their Gene Expression?

Gladstone in the News August 12, 2022

What If Cells Kept Receipts of Their Gene Expression?

Wired—Measuring which genes are on and which are off in a cell usually requires killing it, meaning any measurement is simply a snapshot in time. Seth Shipman explains how his lab has circumvented this problem by re-engineering parts of a bacterial immune system to create a record of molecular events within a cell.

Gladstone Experts Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing

New DNA ‘Camcorders’ Can Record ‘Movies’ of a Cell’s Development Through Time

Gladstone in the News August 2, 2022

New DNA ‘Camcorders’ Can Record ‘Movies’ of a Cell’s Development Through Time

Singularity Hub—Genomics tools allow scientists to get a glimpse of what genes are turned on in a cell at one particular moment, but understanding how genes are turned on or off over time, and in what order, has been impossible. Gladstone Investigator Seth Shipman has developed a biological recorder that keeps track of these events, offering a window into how cells change over time.

Gladstone Experts Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing

Why Federal Government Is Putting Second COVID Boosters ‟On Hold” for People under 50

Gladstone in the News July 26, 2022

Why Federal Government Is Putting Second COVID Boosters ‟On Hold” for People under 50

ABC7 News—The federal government plans to roll out a new vaccine against the BA.5 Omicron variant now predominant in the US early this fall. Senior Investigator Warner Greene, MD, PhD, says that you might want to hold off for your next booster shot until you can get this new vaccine, which will offer better protection against currently circulating variants.

Gladstone Experts COVID-19 Center for HIV Cure Research Virology Greene Lab

Researchers Find SARS-CoV-2 Antibodies Less Effective against Omicron

Gladstone in the News July 25, 2022

Researchers Find SARS-CoV-2 Antibodies Less Effective against Omicron

The Daily Californian—Senior Investigator Melanie Ott, MD, PhD, and collaborator Abdullah Syed, PhD, a postdoctoral fellow in the laboratory of Senior Investigator Jennifer Doudna, explain how they discovered that antibodies against early versions of the SARS-CoV-2 virus do not protect well against the now widespread and highly contagious Omicron variant, and recommend masking to avoid new infections.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media